Vital Therapies reported $-24357000 in EBIT for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Dynavax Technologies DVAX:US USD 63.77M 1.93M
Enanta Pharmaceuticals ENTA:US USD -30013000 2.96M
Insmed INSM:US USD -153275000 30.82M
Intercept Pharmaceuticals ICPT:US USD -17985000 7.84M
Mirati Therapeutics MRTX:US USD -211723000 25.28M
Omeros OMER:US USD -40138000 10.63M
Orasure Technologies OSUR:US USD 13.28M 5.85M
Quidel QDEL:US USD 112.9M 29.7M
Revance Therapeutics RVNC:US USD -74622000 2.86M
Ultragenyx Pharmaceutical RARE:US USD -145628000 79.44M
United Therapeutics UTHR:US USD 186.8M 127.5M
Vital Therapies VTL:US USD -24357000 4.24M
Xoma XOMA:US USD -6210000 1.84M